Influence of the position and size of the hyperfunctioning parathyroid gland on intraoperative PTH levels collected from the ipsilateral jugular and peripheral veins
Bruno Simaan França, Edgar Alexandre Aviles Sandoval, Felipe Ferraz Magnabosco, Climério Pereira do Nascimento Junior, Sérgio Samir Arap, Marília D’Elboux Guimarães Brescia, Fabio Luiz de Menezes Montenegro
Abstract
Introduction: Primary hyperparathyroidism (PHPT) has an estimated prevalence of 0.78%. Its most frequent presentation is sporadic and uniglandular. In surgical treatment, the measurement of intraoperative parathyroid hormone (IOPTH) is fundamental in ensuring therapeutic success. The position and size of the hyperfunctioning parathyroid gland may influence baseline IOPTH values at different collection sites. Objective: Examine the relationship between the position and size of the parathyroid gland and baseline IOPTH values from the ipsilateral internal jugular vein (PTH-c), peripheral vein (PTH-p), and the absolute and percentage differences between these measurements (ΔPTHc-p and Δ%PTHc-p). Methods: A retrospective analysis was conducted on patients undergoing parathyroidectomy for sporadic uniglandular PHPT. Results: Of the 300 eligible patients, 54 were males and 246 females, with a median age of 59 years. Right superior glands exhibited larger volumes and higher ΔPTHc-p and Δ%PTHc-p values compared with the right inferior glands. Left superior glands displayed higher Δ%PTHc-p values than the left inferior glands. Larger glands showed increased PTH-p, PTH-c, and ΔPTHp-c values. No correlation was found between volume and Δ%PTHp-c. Conclusion: The position of the parathyroid gland, either superior or inferior, influences the difference between PTH-c and PTH-p values. Glandular volume correlates with ΔPTHc-p but not with Δ%PTHc-p. Elevated Δ%PTHc-p measurements may be of intraoperative significance, indicating a superior position of the gland.
Keywords
References
1. Minisola S, Arnold A, Belaya Z, Brandi ML, Clarke BL, Hannan FM, Hofbauer LC, Insogna KL, Lacroix A, Liberman U, Palermo A, Pepe J, Rizzoli R, Wermers R, Thakker RV. Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism. J Bone Miner Res. 2022;37(11):2315-29. http://dx.doi.org/10.1002/jbmr.4665. PMid:36245271.
2. Eufrazino C, Veras A, Bandeira F. Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the city of Recife, Brazil. Clin Med Insights Endocrinol Diabetes. 2013;6:69-74. http://dx.doi.org/10.4137/CMED.S13147. PMid:24348080.
3. Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005;132(3):359-72. http://dx.doi.org/10.1016/j.otohns.2004.10.005. PMid:15746845.
4. Tibblin S, Bondeson AG, Bondeson L, Ljungberg O. Surgical strategy in hyperparathyroidism due to solitary adenoma. Ann Surg. 1984;200(6):776-84. http://dx.doi.org/10.1097/00000658-198412000-00018. PMid:6508409.
5. Irvin GL III, Dembrow VD, Prudhomme DL. Operative monitoring of parathyroid gland hyperfunction. Am J Surg. 1991;162(4):299-302. http://dx.doi. org/10.1016/0002-9610(91)90135-Z. PMid:1683177.
6. Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL III. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery. 2003;134(6):973-9. http://dx.doi. org/10.1016/j.surg.2003.06.001. PMid:14668730.
7. Woodrum DT, Saunders BD, England BG, Burney RE, Doherty GM, Gauger PG. The influence of sample site on intraoperative PTH monitoring during parathyroidectomy. Surgery. 2004;136(6):1169-75. http://dx.doi.org/10.1016/j. surg.2004.06.043. PMid:15657572.
8. Abdel-Misih SRZ, Broome JT, Li X, Arrese D, Jacobs JK, Chambers EP, Phay JE. Changing intraoperative parathyroid hormone collection sites from peripheral to central does not affect predictive accuracy during minimally invasive parathyroidectomy. Ann Surg Oncol. 2011;18(3):771-6. http://dx.doi.org/10.1245/ s10434-010-1375-7. PMid:20949324.
9. Beyer TD, Chen E, Ata A, DeCresce R, Prinz RA, Solorzano CC. A prospective evaluation of the effect of sample collection site on intraoperative parathormone monitoring during parathyroidectomy. Surgery. 2008;144(4):504-10. http://dx.doi. org/10.1016/j.surg.2008.07.004. PMid:18847632.
10. Broome JT, Schrager JJ, Bilheimer D, Chambers EP, Jacobs JK, Phay J. Central venous sampling for intraoperative parathyroid hormone monitoring: are peripheral guidelines applicable? Am Surg. 2007;73(7):712-6. http://dx.doi. org/10.1177/000313480707300716. PMid:17674948.
11. Caxeiro GL, Romero RD, Ribeiro DK. Analysis of central and peripheral pth decay values in patients with primary hyperparathyroidism. Arch Head Neck Surg. 2021;50:e20210013. http://dx.doi.org/10.4322/ahns.2021.0013.
12. Maceri DR, Kokot N, Green K, Montgomery V, Sharifi J. Split central venous sampling of parathyroid hormone: an adjunct to surgical exploration. Head Neck. 2011;33(12):1715-8. http://dx.doi.org/10.1002/hed.21659. PMid:21322077.
13. Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W. Utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing in guiding patients with a negative sestamibi scan for minimally invasive parathyroidectomy-a randomized controlled trial. Langenbecks Arch Surg. 2009;394(5):827-35. http://dx.doi.org/10.1007/s00423-009-0516-6. PMid:19529955.
14. Ito F, Sippel R, Lederman J, Chen H. The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg. 2007;245(6):959- 63. http://dx.doi.org/10.1097/01.sla.0000255578.11198.ff. PMid:17522522.
15. Alvarado R, Meyer-Rochow G, Sywak M, Delbridge L, Sidhu S. Bilateral internal jugular venous sampling for parathyroid hormone determination in patients with nonlocalizing primary hyperparathyroidism. World J Surg. 2010;34(6):1299-303. http://dx.doi.org/10.1007/s00268-010-0556-7. PMid:20372897.
16. Alakuş H, Göksu M, Çoraplı M. Is bilateral jugular venous sampling a suitable strategy for primary hyperparathyroidism cases with parathyroid glands that cannot be localized with Sestamibi? Cumhuriyet Medical Journal. 2021;43(4):404- 12. http://dx.doi.org/10.7197/cmj.946660.
17. Ribeiro DK, Lera MM, Fonseca ABR, Neves MC. Analysis of PTH serum concentration from internal jugular veins of patients with primary hyperparathyroidism. Arch Head Neck Surg. 2019;48(2):e00222019. http://dx.doi.org/10.4322/ ahns.2019.0011.
18. Gowrishankar SV, Bidaye R, Das T, Majcher V, Fish B, Casey R, Masterson L. Intrathyroidal parathyroid adenomas: scoping review on clinical presentation, preoperative localization, and surgical treatment. Head Neck. 2023;45(3):706-20. http://dx.doi.org/10.1002/hed.27287. PMid:36563301.
19. Wafae N, Hirose K, Franco C, Wafae GC, Ruiz CR, Daher L, Person OC. The anatomy of the human thyroid veins and its surgical application. Folia Morphol. 2008;67(4):221-5. PMid:19085858.
20. Taslakian B, Trerotola SO, Sacks B, Oklu R, Deipolyi A. The essentials of parathyroid hormone venous sampling. Cardiovasc Intervent Radiol. 2017;40(1):9-21. http:// dx.doi.org/10.1007/s00270-016-1481-4. PMid:27796535.
Submitted date:
07/03/2023
Accepted date:
09/24/2023
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email